FDA Inspection 1095885 — Keystone Bioanalytical, Inc.
The FDA completed an inspection of Keystone Bioanalytical, Inc. on June 28, 2019 in North Wales, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 28, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North Wales, PA (United States)
Additional Details
Bioanalytical BA/BE